Manufacturers of the diabetes drug Actos have spent much of 2011 facing questions about the...
Fosamax is manufactured by Merck and Company, Inc. and was approved on September 29, 1995. This drug is used to treat osteoporosis in post-menopausal women and taken orally in tablet or solution form. Bisphosphonates is the classification for Fosamax and is marketed under other brand names: Actonel, Actonel+Ca, Aredia, Boniva, Didronel, Reclast, Skelid, and Zometa. The generic name for Fosamax, Fosamax+D, and Fosamax solution is alendronate.
Fosamax side effects of the body systems include: gastrointestinal, metabolic, musculoskeletal, nervous system, dermatologic, ocular, and respiratory. Side effects associated with Fosamax are categorized as common and severe. While most patients tolerate common Fosamax side effects well, osteonecrosis (dead jaw or ONJ) is the most serious of the known side effects.
Musculoskeletal related Fosamax side effects are marked by pain in the bones, muscles, or joints. Report significant pain in the hip and thigh areas to a physician as this may indicate a serious medical condition. Initial gastrointestinal changes include: constipation and/or diarrhea, feeling bloated or full, and gas. Other common side effects are: headache, mild stomach pain, nausea, taste changes, and vomiting (consult a physician if these side effects become bothersome).
Common Fosamax side effects that worsen are considered severe. A partial list of allergic reactions are blistering or peeling of the skin, blood in the stool or severe changes noted, severe or new heartburn symptoms, painful or difficulty swallowing, persistent sore throat, swelling anywhere on the body, or trouble breathing.
Osteonecrosis of the jaw (ONJ or dead jaw) is bone deterioration of the jaw resulting in collapse (as a result of infection). Before taking Fosamax inform a physician if dental work was recently performed to assess possible infection risks. Also, consult with a physician prior to dental work performed, particularly tooth extraction or surgery. If pain, numbness or tingling, swelling, or changes in the jaw area are experienced, contact a physician immediately.
The combination of Naproxen and Fosamax drugs may result in gastric ulcers. Post-marketing Fosamax side effects reported esophagus maladies: esophagitis, esophageal erosions, esophageal ulcers, rarely esophageal stricture or perforation and oropharyngeal ulceration.
Patients should report any Fosamax side effects experienced that are unusual or not on the list of side effects. It is important to assess the severity of Fosamax side effects in order to receive the proper medical intervention. If a patient experience bothersome common side effects, consult with your physician for medical advice. Seek immediate medical attention for side effects that are severe, unusually bothersome, or persistent.